Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
Robert Baranello, Krishna Bharani, Vasudevaraju Padmaraju, et al.
Current Alzheimer Research (2015) Vol. 12, Iss. 1, pp. 32-46
Open Access | Times Cited: 291

Showing 1-25 of 291 citing articles:

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle, Benjamin Grenier‐Boley, Rebecca Sims, et al.
Nature Genetics (2019) Vol. 51, Iss. 3, pp. 414-430
Open Access | Times Cited: 2459
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Barry Boland, Wen H. Yu, Olga Corti, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 660-688
Open Access | Times Cited: 467
Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
Yun Zhang, Huaqiu Chen, Ran Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 351
Genetic diversity fuels gene discovery for tobacco and alcohol use
Gretchen Saunders, Xingyan Wang, Fang Chen, et al.
Nature (2022) Vol. 612, Iss. 7941, pp. 720-724
Open Access | Times Cited: 296
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Ghulam Hussain, Azhar Rasul, Haseeb Anwar, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 3, pp. 341-357
Open Access | Times Cited: 277
The identity and function of microglia in neurodegeneration
Wilbur M. Song, Marco Colonna
Nature Immunology (2018) Vol. 19, Iss. 10, pp. 1048-1058
Closed Access | Times Cited: 275
β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease
Xiaojuan Sun, Weidong Chen, Yan‐Dong Wang
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 258
Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
Jaume Folch, Dmitry S. Petrov, Miren Ettcheto, et al.
Neural Plasticity (2016) Vol. 2016, pp. 1-15
Open Access | Times Cited: 257
Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
Stéphanie Andrade, Maria João Ramalho, Joana A. Loureiro, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2313-2313
Open Access | Times Cited: 201
Lymphatic drainage system of the brain: A novel target for intervention of neurological diseases
Bao‐liang Sun, Lihua Wang, Tuo Yang, et al.
Progress in Neurobiology (2017) Vol. 163-164, pp. 118-143
Closed Access | Times Cited: 200
Protein Misfolding and Aggregation in Alzheimer’s Disease and Type 2 Diabetes Mellitus
Ghulam Md Ashraf, Nigel H. Greig, Taqi Ahmed Khan, et al.
CNS & Neurological Disorders - Drug Targets (2014) Vol. 13, Iss. 7, pp. 1280-1293
Open Access | Times Cited: 199
Recent progress of drug nanoformulations targeting to brain
Abdur Rauf Khan, Xiaoye Yang, Manfei Fu, et al.
Journal of Controlled Release (2018) Vol. 291, pp. 37-64
Closed Access | Times Cited: 182
Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy
Shu-Hui Xin, Lin Tan, Xi‐Peng Cao, et al.
Neurotoxicity Research (2018) Vol. 34, Iss. 3, pp. 733-748
Closed Access | Times Cited: 172
The Role of Astrocytes in the Central Nervous System Focused on BK Channel and Heme Oxygenase Metabolites: A Review
Yong Hee Kim, Jin‐Hong Park, Yoon Kyung Choi
Antioxidants (2019) Vol. 8, Iss. 5, pp. 121-121
Open Access | Times Cited: 169
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Haoshen Shi, Yosef Koronyo, Altan Rentsendorj, et al.
Acta Neuropathologica (2020) Vol. 139, Iss. 5, pp. 813-836
Open Access | Times Cited: 167
Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy
Natalia N. Nalivaeva, Anthony J. Turner
British Journal of Pharmacology (2019) Vol. 176, Iss. 18, pp. 3447-3463
Open Access | Times Cited: 145
Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
Teresa Pardo-Moreno, Anabel González‐Acedo, Antonio Rivas-Domínguez, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1117-1117
Open Access | Times Cited: 129
Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration
Natalia N. Nalivaeva, Anthony J. Turner, И. А. Журавин
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 143
Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: An integrative review
Mark J. Millan
Progress in Neurobiology (2017) Vol. 156, pp. 1-68
Closed Access | Times Cited: 137
Mitochondrial Dysfunction and Alzheimer’s Disease: Role of Microglia
Ishan Agrawal, Sushmita Jha
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 137
Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases
Fang Luo, Aaron F. Sandhu, Wiramon Rungratanawanich, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7174-7174
Open Access | Times Cited: 129
Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances
John J.V. McMurray
European Journal of Heart Failure (2015) Vol. 17, Iss. 3, pp. 242-247
Open Access | Times Cited: 120
Therapeutic Strategies Targeting Amyloid-β in Alzheimer’s Disease
Lídia Pinheiro, Célia Faustino
Current Alzheimer Research (2019) Vol. 16, Iss. 5, pp. 418-452
Closed Access | Times Cited: 115
BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
Gerald Koelsch
Molecules (2017) Vol. 22, Iss. 10, pp. 1723-1723
Open Access | Times Cited: 108
Dementia‐related adverse events in PARADIGM‐HF and other trials in heart failure with reduced ejection fraction
Jane A. Cannon, Li Shen, Pardeep S. Jhund, et al.
European Journal of Heart Failure (2016) Vol. 19, Iss. 1, pp. 129-137
Open Access | Times Cited: 106
Page 1 - Next Page

Scroll to top